Literature DB >> 30355151

RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.

Jeffrey W Hofmann1, William W Seeley1,2, Eric J Huang1,3.   

Abstract

Frontotemporal dementia is a group of early onset dementia syndromes linked to underlying frontotemporal lobar degeneration (FTLD) pathology that can be classified based on the formation of abnormal protein aggregates involving tau and two RNA binding proteins, TDP-43 and FUS. Although elucidation of the mechanisms leading to FTLD pathology is in progress, recent advances in genetics and neuropathology indicate that a majority of FTLD cases with proteinopathy involving RNA binding proteins show highly congruent genotype-phenotype correlations. Specifically, recent studies have uncovered the unique properties of the low-complexity domains in RNA binding proteins that can facilitate liquid-liquid phase separation in the formation of membraneless organelles. Furthermore, there is compelling evidence that mutations in FTLD genes lead to dysfunction in diverse cellular pathways that converge on the endolysosomal pathway, autophagy, and neuroinflammation. Together, these results provide key mechanistic insights into the pathogenesis and potential therapeutic targets of FTLD.

Entities:  

Keywords:  ALS; FTD; FTLD; FUS; RNA binding proteins; TDP-43; amyotrophic lateral sclerosis; frontotemporal dementia; frontotemporal lobar degeneration; hydrogels; liquid droplets; low-complexity domain

Mesh:

Substances:

Year:  2018        PMID: 30355151      PMCID: PMC6731550          DOI: 10.1146/annurev-pathmechdis-012418-012955

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  152 in total

1.  Kinesin transports RNA: isolation and characterization of an RNA-transporting granule.

Authors:  Yoshimitsu Kanai; Naoshi Dohmae; Nobutaka Hirokawa
Journal:  Neuron       Date:  2004-08-19       Impact factor: 17.173

2.  Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation.

Authors:  Judith Aharon-Peretz; Samih Badarny; Hanna Rosenbaum; Ruth Gershoni-Baruch
Journal:  Neurology       Date:  2005-09-07       Impact factor: 9.910

3.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Authors:  Alfredo Ramirez; André Heimbach; Jan Gründemann; Barbara Stiller; Dan Hampshire; L Pablo Cid; Ingrid Goebel; Ammar F Mubaidin; Abdul-Latif Wriekat; Jochen Roeper; Amir Al-Din; Axel M Hillmer; Meliha Karsak; Birgit Liss; C Geoffrey Woods; Maria I Behrens; Christian Kubisch
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

4.  Frontotemporal dementia: clinicopathological correlations.

Authors:  Mark S Forman; Jennifer Farmer; Julene K Johnson; Christopher M Clark; Steven E Arnold; H Branch Coslett; Anjan Chatterjee; Howard I Hurtig; Jason H Karlawish; Howard J Rosen; Vivianna Van Deerlin; Virginia M-Y Lee; Bruce L Miller; John Q Trojanowski; Murray Grossman
Journal:  Ann Neurol       Date:  2006-06       Impact factor: 10.422

5.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.

Authors:  Marc Cruts; Ilse Gijselinck; Julie van der Zee; Sebastiaan Engelborghs; Hans Wils; Daniel Pirici; Rosa Rademakers; Rik Vandenberghe; Bart Dermaut; Jean-Jacques Martin; Cornelia van Duijn; Karin Peeters; Raf Sciot; Patrick Santens; Tim De Pooter; Maria Mattheijssens; Marleen Van den Broeck; Ivy Cuijt; Krist'l Vennekens; Peter P De Deyn; Samir Kumar-Singh; Christine Van Broeckhoven
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

Review 6.  Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia.

Authors:  Bradley F Boeve; Anthony E Lang; Irene Litvan
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

7.  Distribution of saposins (sphingolipid activator proteins) in tissues of lysosomal storage disease patients.

Authors:  M Tayama; J S O'Brien; Y Kishimoto
Journal:  J Mol Neurosci       Date:  1992       Impact factor: 3.444

Review 8.  Saposins: structure, function, distribution, and molecular genetics.

Authors:  Y Kishimoto; M Hiraiwa; J S O'Brien
Journal:  J Lipid Res       Date:  1992-09       Impact factor: 5.922

9.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17.

Authors:  Matt Baker; Ian R Mackenzie; Stuart M Pickering-Brown; Jennifer Gass; Rosa Rademakers; Caroline Lindholm; Julie Snowden; Jennifer Adamson; A Dessa Sadovnick; Sara Rollinson; Ashley Cannon; Emily Dwosh; David Neary; Stacey Melquist; Anna Richardson; Dennis Dickson; Zdenek Berger; Jason Eriksen; Todd Robinson; Cynthia Zehr; Chad A Dickey; Richard Crook; Eileen McGowan; David Mann; Bradley Boeve; Howard Feldman; Mike Hutton
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

10.  The prevalence of frontotemporal dementia.

Authors:  E Ratnavalli; C Brayne; K Dawson; J R Hodges
Journal:  Neurology       Date:  2002-06-11       Impact factor: 9.910

View more
  12 in total

Review 1.  Liquid-Liquid Phase Separation and Its Mechanistic Role in Pathological Protein Aggregation.

Authors:  W Michael Babinchak; Witold K Surewicz
Journal:  J Mol Biol       Date:  2020-03-10       Impact factor: 5.469

2.  Refining All-Atom Protein Force Fields for Polar-Rich, Prion-like, Low-Complexity Intrinsically Disordered Proteins.

Authors:  Wai Shing Tang; Nicolas L Fawzi; Jeetain Mittal
Journal:  J Phys Chem B       Date:  2020-10-20       Impact factor: 2.991

Review 3.  Social cognition in the FTLD spectrum: evidence from MRI.

Authors:  Maria Antonietta Magno; Elisa Canu; Massimo Filippi; Federica Agosta
Journal:  J Neurol       Date:  2021-11-19       Impact factor: 4.849

4.  ALS/FTD-associated protein FUS induces mitochondrial dysfunction by preferentially sequestering respiratory chain complex mRNAs.

Authors:  Yueh-Lin Tsai; Tristan H Coady; Lei Lu; Dinghai Zheng; Isabel Alland; Bin Tian; Neil A Shneider; James L Manley
Journal:  Genes Dev       Date:  2020-05-07       Impact factor: 11.361

Review 5.  Role of CPEB3 protein in learning and memory: new insights from synaptic plasticity.

Authors:  Wen Rui Qu; Qi Han Sun; Qian Qian Liu; Hong Juan Jin; Ran Ji Cui; Wei Yang; De Biao Song; Bing Jin Li
Journal:  Aging (Albany NY)       Date:  2020-07-02       Impact factor: 5.682

Review 6.  Pathological phase transitions in ALS-FTD impair dynamic RNA-protein granules.

Authors:  Natalia B Nedelsky; J Paul Taylor
Journal:  RNA       Date:  2021-10-27       Impact factor: 4.942

Review 7.  Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes-Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism.

Authors:  Patrycja Krzosek; Natalia Madetko; Anna Migda; Bartosz Migda; Dominika Jaguś; Piotr Alster
Journal:  Front Aging Neurosci       Date:  2022-02-09       Impact factor: 5.750

Review 8.  Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration.

Authors:  Juan García-Revilla; Antonio Boza-Serrano; Ana M Espinosa-Oliva; Manuel Sarmiento Soto; Tomas Deierborg; Rocío Ruiz; Rocío M de Pablos; Miguel Angel Burguillos; Jose L Venero
Journal:  Cell Death Dis       Date:  2022-07-20       Impact factor: 9.685

9.  RNA Binding Motif 5 (RBM5) in the CNS-Moving Beyond Cancer to Harness RNA Splicing to Mitigate the Consequences of Brain Injury.

Authors:  Travis C Jackson; Patrick M Kochanek
Journal:  Front Mol Neurosci       Date:  2020-07-15       Impact factor: 5.639

10.  Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency.

Authors:  Jiasheng Zhang; Dmitry Velmeshev; Kei Hashimoto; Yu-Hsin Huang; Jeffrey W Hofmann; Xiaoyu Shi; Jiapei Chen; Andrew M Leidal; Julian G Dishart; Michelle K Cahill; Kevin W Kelley; Shane A Liddelow; William W Seeley; Bruce L Miller; Tobias C Walther; Robert V Farese; J Paul Taylor; Erik M Ullian; Bo Huang; Jayanta Debnath; Torsten Wittmann; Arnold R Kriegstein; Eric J Huang
Journal:  Nature       Date:  2020-08-31       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.